Structure Therapeutics Announces Participation in Upcoming Investor Conferences
Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company focusing on novel oral small molecule therapeutics for metabolic and cardiopulmonary diseases, has announced its participation in two upcoming investor conferences in September 2024:
1. Morgan Stanley 22nd Annual Global Healthcare Conference: Fireside chat on Thursday, September 5 at 10:00 a.m. EDT
2. Cantor Fitzgerald Global Healthcare Conference 2024: Fireside chat on Thursday, September 19 at 9:10 a.m. EDT
Live and archived webcasts of both fireside chats will be available on the company's website, with replays accessible for 90 days after the events.
Structure Therapeutics Inc. (NASDAQ: GPCR), un'azienda biofarmaceutica globale in fase clinica che si concentra su nuovi farmaci molecolari orali per malattie metaboliche e cardiopolmonari, ha annunciato la sua partecipazione a due prossime conferenze per investitori a settembre 2024:
1. 22ª Conferenza Annuale sulla Salute Globale di Morgan Stanley: Conversazione al caminetto giovedì 5 settembre alle 10:00 EDT
2. Conferenza sulla Salute Globale di Cantor Fitzgerald 2024: Conversazione al caminetto giovedì 19 settembre alle 9:10 EDT
Le dirette e le registrazioni archiviate di entrambe le conversazioni al caminetto saranno disponibili sul sito web della società, con riproduzioni accessibili per 90 giorni dopo gli eventi.
Structure Therapeutics Inc. (NASDAQ: GPCR), una compañía biofarmacéutica global en etapa clínica que se enfoca en nuevos terapéuticos orales de pequeñas moléculas para enfermedades metabólicas y cardiopulmonares, ha anunciado su participación en dos próximas conferencias para inversionistas en septiembre de 2024:
1. 22ª Conferencia Anual de Salud Global de Morgan Stanley: Charla junto al fuego el jueves 5 de septiembre a las 10:00 a.m. EDT
2. Conferencia Global de Salud de Cantor Fitzgerald 2024: Charla junto al fuego el jueves 19 de septiembre a las 9:10 a.m. EDT
Las transmisiones en vivo y grabadas de ambas charlas estarán disponibles en el sitio web de la compañía, con repeticiones accesibles durante 90 días después de los eventos.
Structure Therapeutics Inc. (NASDAQ: GPCR), 신진 대사 및 심폐 질환을 위한 새로운 경구 소분자의 약물 치료에 중점을 둔 임상 단계의 글로벌 생명공학 회사가 2024년 9월에 있을 두 개의 투자자 회의에 참여할 것이라고 발표했습니다:
1. 모건 스탠리 제22회 글로벌 헬스케어 컨퍼런스: 9월 5일 목요일 오전 10:00 EDT에 화상 대화 진행
2. 칸토르 피츠제럴드 글로벌 헬스케어 컨퍼런스 2024: 9월 19일 목요일 오전 9:10 EDT에 화상 대화 진행
두 화상 대화의 생중계 및 기록된 웹캐스트는 회사 웹사이트에서 제공되며, 이벤트 후 90일 동안 다시 볼 수 있습니다.
Structure Therapeutics Inc. (NASDAQ: GPCR), une entreprise biopharmaceutique mondiale en phase clinique spécialisée dans les nouveaux thérapeutiques oraux à petites molécules pour les maladies métaboliques et cardiopulmonaires, a annoncé sa participation à deux conférences pour investisseurs à venir en septembre 2024 :
1. 22e Conférence Annuelle Mondiale de la Santé de Morgan Stanley : Discussion au coin du feu le jeudi 5 septembre à 10h00 EDT
2. Conférence Mondiale de la Santé de Cantor Fitzgerald 2024 : Discussion au coin du feu le jeudi 19 septembre à 9h10 EDT
Les webcasts en direct et archivés des deux discussions seront disponibles sur le site Web de l'entreprise, avec des rediffusions accessibles pendant 90 jours après les événements.
Structure Therapeutics Inc. (NASDAQ: GPCR), ein globales biopharmazeutisches Unternehmen in der klinischen Phase, das sich auf neuartige orale niedermolekulare Therapeutika für Stoffwechsel- und kardiopulmonale Erkrankungen spezialisiert hat, hat seine Teilnahme an zwei kommenden Investorenkonferenzen im September 2024 bekannt gegeben:
1. 22. Jährliche Globale Gesundheitskonferenz von Morgan Stanley: Gespräch am Kamin am Donnerstag, den 5. September um 10:00 Uhr EDT
2. Globale Gesundheitskonferenz von Cantor Fitzgerald 2024: Gespräch am Kamin am Donnerstag, den 19. September um 9:10 Uhr EDT
Die Live-Übertragungen und die archivierten Webcasts beider Gespräche werden auf der Website des Unternehmens verfügbar sein, mit Wiederholungen, die 90 Tage nach den Veranstaltungen zugänglich sind.
- None.
- None.
SAN FRANCISCO, Aug. 26, 2024 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic and cardiopulmonary diseases, today announced management will participate at the following investor conferences in September:
- Morgan Stanley 22nd Annual Global Healthcare Conference
Fireside chat: Thursday, September 5 at 10:00 a.m. EDT
- Cantor Fitzgerald Global Healthcare Conference 2024
Fireside chat: Thursday, September 19 at 9:10 a.m. EDT
Live and archived webcasts of the fireside chats will be accessible from the company’s website https://ir.structuretx.com/events-presentations/events. Replays of the webcasts will be available for 90 days.
About Structure Therapeutics
Structure Therapeutics is a science-driven clinical-stage biopharmaceutical company focused on discovering and developing innovative oral small molecule treatments for chronic metabolic and cardiopulmonary conditions with significant unmet medical needs. Utilizing its next generation structure-based drug discovery platform, the Company has established a robust GPCR-targeted pipeline, featuring multiple wholly-owned proprietary clinical-stage small molecule compounds designed to surpass the scalability limitations of traditional biologic and peptide therapies and be accessible to more patients around the world. For additional information, please visit www.structuretx.com.
Investors:
Danielle Keatley
Structure Therapeutics Inc.
ir@structuretx.com
Media:
Dan Budwick
1AB
Dan@1abmedia.com
FAQ
When is Structure Therapeutics (GPCR) participating in the Morgan Stanley Healthcare Conference?
What is the date for Structure Therapeutics' (GPCR) presentation at the Cantor Fitzgerald Global Healthcare Conference 2024?
How can investors access Structure Therapeutics' (GPCR) conference presentations?
What type of therapeutics is Structure Therapeutics (GPCR) developing?
